Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

1.60p
   
  • Change Today:
    -0.016p
  • 52 Week High: 3.96
  • 52 Week Low: 1.17
  • Currency: UK Pounds
  • Shares Issued: 1,341.82m
  • Volume: 3,035,653
  • Market Cap: £21.46m
  • RiskGrade: 340

Regulatory News

Total Voting Rights 28-Mar-2024 07:00 RNS
Placing to Raise US$4.2 million 29-Feb-2024 07:00 RNS
CBR Brain Delivery 16-Feb-2024 07:00 RNS
CBR Intranasal Delivery 14-Feb-2024 07:00 RNS
FDA Consents to Phase I Trials of HEMO-CAR-T 09-Feb-2024 07:00 RNS
Approval and Issuance of U.S. Conditioning Patent 02-Feb-2024 07:00 RNS
Submission of Complete Response to Clinical Hold 16-Jan-2024 07:00 RNS
HEMO-CAR-T Process Qualification Run Completed 08-Jan-2024 07:00 RNS
Placing to Raise £534,375 28-Nov-2023 12:19 RNS
CBR Expanded to Treatment of Cancer 27-Nov-2023 07:00 RNS
Lentivirus Re-manufacturing Completed 15-Nov-2023 07:00 RNS
Total Voting Rights 31-Oct-2023 07:00 RNS
Half-year Report 28-Sep-2023 12:28 RNS
Strategic Investment from Prevail Partners, LLC 18-Sep-2023 07:00 RNS
Clinical Hold Lift Plan is accepted by FDA 14-Sep-2023 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 1.60p
Change Today -0.016p
% Change -0.99 %
52 Week High 3.96
52 Week Low 1.17
Volume 3,035,653
Shares Issued 1,341.82m
Market Cap £21.46m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.96% below the market average46.96% below the market average46.96% below the market average46.96% below the market average46.96% below the market average
66.04% below the sector average66.04% below the sector average66.04% below the sector average66.04% below the sector average66.04% below the sector average
Price Trend
35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average35.01% below the market average
40.35% above the sector average40.35% above the sector average40.35% above the sector average40.35% above the sector average40.35% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 15-Apr-2024

Time Volume / Share Price
16:42 250,000 @ 1.59p
16:28 1,229 @ 1.62p
16:28 3,241 @ 1.62p
16:24 6,164 @ 1.61p
16:22 1,232 @ 1.61p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page